China Shineway Pharmaceutical Group Ltd ADR (CSWYY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in China Shineway Pharmaceutical Group Ltd ADR, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

China Shineway Pharmaceutical Group Ltd ADR (CSWYY) has returned 0.00% so far this year and 11.72% over the past 12 months.

Based on dividend-adjusted daily data since Jul 22, 2020, CSWYY's average daily return is +0.04%, while the average monthly return is +0.73%. At this rate, your investment would double in approximately 7.9 years.

Historically, 16% of months were positive and 84% were negative. The best month was Jan 2023 with a return of +55.1%, while the worst month was Sep 2022 at -42.2%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 2 months.

On a daily basis, CSWYY closed higher 4% of trading days. The best single day was Jan 24, 2023 with a return of +54.8%, while the worst single day was Sep 20, 2022 at -38.6%.

China Shineway Pharmaceutical Group Ltd ADR has an annualized alpha of 10.75%, beta of 0.02, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since July 23, 2020.

• This stock participated in 67.41% of S&P 500 Index downside but only 45.14% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.02 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CSWYY ranks 82 for risk / return — in the top 82% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for China Shineway Pharmaceutical Group Ltd ADR (CSWYY) and compare them to a chosen benchmark (S&P 500 Index).

China Shineway Pharmaceutical Group Ltd ADR provided a 6.86% dividend yield over the last twelve months, with an annual payout of $1.30 per share.

The table displays the monthly dividend distributions for China Shineway Pharmaceutical Group Ltd ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the China Shineway Pharmaceutical Group Ltd ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the China Shineway Pharmaceutical Group Ltd ADR was 45.23%, occurring on Oct 14, 2022. Recovery took 162 trading sessions.

The current China Shineway Pharmaceutical Group Ltd ADR drawdown is 22.05%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of China Shineway Pharmaceutical Group Ltd ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how China Shineway Pharmaceutical Group Ltd ADR is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.